Charity Impact Media

Home › Medical research

Cardiovascular Research Foundation

New York, NY · EIN 52-1752653 · 501(c)(3) · Publicly supported organization (509(a)(2))
Latest filing: Form 990 for calendar year 2024 (tax year 2024) · View the filing · Correct or respond

Cardiovascular Research Foundation reported $68.9 million in revenue and $66.7 million in expenses for calendar year 2024. Of every $100 it spent, $87.53 went to program services, $12.41 to management and general costs and $0.06 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 87.0% of the total. The highest compensation it reported for one person was $1,002,558 (CEO & DIRECTOR). 86 people received more than $100,000 in reportable compensation. Revenue rose 5% between 2019 and 2024. Source: Form 990, 2024.

Where $100 of spending went

Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $67M

For context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).

Where $100 of revenue came from

Calendar year 2024 · Form 990, Part VIII · total revenue $69M

Other revenue was negative: −$127K. The bar shows the positive sources only.

The 990 scorecard · same measures for every charity, no grades

2024 filing. Median across 169 covered charities in this category, from their latest filings.
Measure2024Median
Program services
Part IX 25(B) ÷ 25(A)
87.5%83.9%
Management & general
Part IX 25(C) ÷ 25(A)
12.4%12.4%
Fundraising
Part IX 25(D) ÷ 25(A)
0.1%0.1%
Fundraising cost per $1 of contributions
Part IX 25(D) ÷ Part VIII 1h
$0.01$0.01
Contributions & grants share of revenue
Part VIII 1h ÷ 12
10.8%72.7%
Government grants share of revenue
Part VIII 1e ÷ 12
0.0%0.0%
Program service revenue share
Part VIII 2g ÷ 12
87.0%5.8%
Highest reported compensation
Part VII-A, columns D–F
$1,002,558$628,890
Highest compensation as share of expenses
Part VII-A ÷ Part IX 25(A)
1.50%1.94%
People paid over $100,000
Part VII, line 2
8618
Net assets, in months of expenses
Part X 33(B) ÷ monthly expenses
9.013.3
Independent voting board members
Part VI 1a–1b
10 of 1193.8%

A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.

What the money paid for, in its own words

2024 · Form 990, Part III · the three largest programs by expense
$19M expenses · 32.7% of program spending · grants $370K · revenue $26M

Clinical trials center - a distinguished academic research organization, the crf clinical trials center (ctc) plans and executes clinical investigations from first-in-man studies to large, multicenter international trials designed to gain insights that will elevate the quality of care in cardiovascular medicine. The ctc specializes in trial design, event adjudication, data and safety monitoring, and bio statistical services. Crf faculty author over 300 articles annually in prestigious medical and scientific journals, bringing the latest research to the global medical community

$6.3M expenses · 10.8% of program spending · grants $190K · revenue $7.6M

Skirball center for innovation - a state of the art innovation center, the crf skirball center for innovation is dedicated to the investigation and validation of novel concepts, treatments, and devices. Our preeminent team of pioneering researchers and thought leaders continually break new ground as they guide early ideas and inventions through comprehensive preclinical research programs to introduce practical therapies into clinical medicine

$11M expenses · 18.6% of program spending · grants $308K · revenue $18M

Tct 2024 (transcatheter cardiovascular therapeutics) meeting - the Cardiovascular Research Foundation (crf) stands at the forefront of education in cardiovascular medicine. This focus reflects the crf faculty's commitment to sharing and disseminating the latest clinical research information to the broadest audience at the earliest possible date. The fundamental goal of crf's education program is to enable the global physician community to apply important new knowledge to actual patient care. Crf's principal annual educational event, transcatheter cardiovascular therapeutics (tct) meeting, is…

$22M all other programs (line 4d)

Highest reported compensation

2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here
RoleFrom this orgFrom related orgsOtherTotal
CEO & DIRECTOR
Director/trustee, officer, 37.50 hrs/week
$933,460$0$69,098$1,002,558
DIRECTOR OF CLINICAL & OUT
Highest compensated employee, 37.50 hrs/week
$700,158$0$36,515$736,673
CFO
Officer, 37.50 hrs/week
$474,963$0$38,684$513,647
CHIEF LEGAL OFFICER
Officer, 37.50 hrs/week
$482,912$0$27,346$510,258
DIRECTOR
Highest compensated employee, 37.50 hrs/week
$461,897$0$23,000$484,897
EXECUTIVE DIRECTOR, CED
Highest compensated employee, 37.50 hrs/week
$431,480$0$23,012$454,492
DIRECTOR RESEARCH
Highest compensated employee, 37.50 hrs/week
$325,318$0$66,884$392,202
DIRECTOR OF HEART FAILURE
Highest compensated employee, 37.50 hrs/week
$315,075$0$56,665$371,740

86 people received more than $100,000 in reportable compensation from Cardiovascular Research Foundation (Part VII, line 2). Compensation of current officers, directors and key employees totaled $2.0M (Part IX, line 5).

6 years of filings

Form 990, Parts I, VII, IX and X · each row is that year's own filing, linked
RevenueExpenses
$0$20M$40M$60M$80M201920202021202220232024$69M$67M
FilingRevenueExpensesProgramsNet assetsTop pay
2024 ⓘ$69M$67M87.5%$50M$1,002,558
2023 ⓘ$78M$65M86.8%$46M$1,017,602
2022 ⓘ$61M$57M86.7%$33M$979,380
2021 ⓘ$52M$47M86.1%$31M$983,062
2020 ⓘ$37M$41M85.5%$25M$848,698
2019 ⓘ$66M$56M88.4%$29M$923,678

Governance answers, as filed

2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means
  • Voting board members, and how many are independent Part VI, lines 1a–1b11 · 10 independent
  • Audited financial statements Part XII 2bYes
  • Conflict-of-interest policy Part VI 12aYes
  • Whistleblower policy Part VI 13Yes
  • Document retention policy Part VI 14Yes
  • Independent process for top executive pay Part VI 15aYes
  • Board given the 990 before filing Part VI 11aYes
  • Family or business ties among insiders Part VI 2No
  • Aware of a significant diversion of assets Part VI 5No
  • Excess benefit transaction with an insider Part IV 25aNo
  • Loans to or from insiders outstanding Part IV 26No
  • Lobbying, or a 501(h) election in effect Part IV 4No
  • Over $15,000 of professional fundraising services Part IV 18Yes
  • Over $10,000 of activity outside the U.S. Part IV 14bYes
  • Employees Part I, line 5213
  • Volunteers Part I, line 610

Largest outside contractors

2024 · Form 990, Part VII, Section B · businesses only
LISSOM CORP
Management consulting
$201,093
FIXED GEAR DESIGNS
Management consulting
$179,393
VERY FINE WORK
Management consulting
$155,870
MATTTHEW SCHWARTZ DESIGN STUDIO LLC
Management consulting
$140,000

Individuals listed as contractors are left out. 9 contractors were paid more than $100,000 in all.

Private foundation grants it received

4 private foundations reported grants to Cardiovascular Research Foundation totaling $270K on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.

Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.

Correct a figure or respond

Every number above is copied from Cardiovascular Research Foundation's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Cardiovascular Research Foundation, you can publish a response that is linked from this page.

Similar-sized charities in this cause

All medical research charities · Largest charities in New York

Questions people ask

How much of Cardiovascular Research Foundation's spending goes to programs?

In calendar year 2024, Cardiovascular Research Foundation reported that 87.5% of its $66.7 million in expenses went to program services, 12.4% to management and general and 0.1% to fundraising (Form 990, Part IX).

How much does Cardiovascular Research Foundation pay its top executive?

The largest total compensation Cardiovascular Research Foundation reported for one person in calendar year 2024 was $1,002,558, for the role of CEO & DIRECTOR (Form 990, Part VII, including compensation from related organizations and other compensation).

Where does Cardiovascular Research Foundation get its money?

Of $68.9 million in revenue in calendar year 2024, 10.8% came from contributions and grants and 87.0% from program service revenue (Form 990, Part VIII).

Is Cardiovascular Research Foundation a registered charity?

The IRS lists EIN 52-1752653 as a 501(c)(3) organization (publicly supported organization (509(a)(2))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.

Sources

  • 2024: Form 990 for calendar year 2024, object 202533189349306528 · read the filing · XML
  • 2023: Form 990 for calendar year 2023, object 202433109349302133 · read the filing
  • 2022: Form 990 for calendar year 2022, object 202312779349300341 · read the filing
  • 2021: Form 990 for calendar year 2021, object 202223079349301717 · read the filing
  • 2020: Form 990 for calendar year 2020, object 202142379349300909 · read the filing
  • 2019: Form 990 for calendar year 2019, object 202003099349302720 · read the filing

All filings for EIN 52-1752653: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.